Komen Scholar: Dr. Lisa Carey
Dr. Lisa Carey, Professor in Breast Cancer Research, Chief of Hematology/Oncology, Physician-in-Chief of the NC Cancert Hospital and Associate Director of Clinical Sciences at Lineberger Comprehensive Cancer Center, focuses on the identification of different subtypes of breast cancer, evaluation of new chemotherapy agents in early breast cancer, and examination of tumor characteristics that predict response to therapy. Dr. Carey’s Komen-funded research aims to evaluate how HER2-positive breast cancer responds to HER2-targeted therapies. This project integrates and analyzes data from over 1,300 women participating in six neoadjuvant clinical trials focusing on HER2-targeted therapies. Dr. Carey was a Komen Scholar from 2010-2018 and has been a Scientific Advisory Board Member since 2018.